,Patient First Name,Patient Last Name,MRN,DOB,Sex,Order Date,COVID19 Component Value,Height,Weight,Temp,Pulse,Systolic BP,Diastolic BP,Smoking Status,Last Pack Years,Medical History,Diagnosis from Problem List,PMH,Last EF Value,Current Medications,ED Vis Last 90 Days,Last ED Visit,ED Visits-Last 30 Days
5,,,601481,1972-07-05,M,2021-10-12,Detected,1.829 m (6'),71.4 kg (157 lb 4.8 oz),36.7 °C (98 °F),67,149,88,Current Every Day Smoker,20.0,"Unspecified retinal detachment
Hypertension
Alcoholic pancreatitis
Chronic alcoholism (HCC)","Dislocation, lens, posterior [H27.139]
Retinal detachment with retinal defect [H33.009]
Severe uncontrolled hypertension [I10]
Alcohol-induced acute pancreatitis, unspecified complication status [K85.20]
Epigastric abdominal pain [R10.13]
Essential hypertension [I10]
Hypertension [I10]
Retinal detachment [H33.20]
Chronic alcoholism (HCC) [F10.20]
Alcoholic pancreatitis [K85.20]
Prolonged Q-T interval on ECG [R94.31]
...","Dislocation, lens, posterior - H27.139; Retinal detachment with retinal defect - H33.009; Severe uncontrolled hypertension - I10; Epigastric abdominal pain - R10.13; Essential hypertension - I10; Hypertension - I10; Retinal detachment - H33.20; Chronic alcoholism (HCC) - F10.20; Alcoholic pancreatitis - K85.20; Prolonged Q-T interval on ECG - R94.31; Perforated duodenal ulcer (HCC) - K26.5; Abdominal pain, unspecified abdominal location - R10.9; Vomiting, intractability of vomiting not specified, presence of nausea not specified, unspecified vomiting type - R11.10; Dehydration - E86.0; Alcohol-induced chronic pancreatitis (HCC) - K86.0; Hyperbilirubinemia - E80.6; Alcoholism (HCC) - F10.20; Acute recurrent pancreatitis - K85.90; Alcohol-induced acute pancreatitis, unspecified complication status - K85.20; Hypokalemia - E87.6; Hypomagnesemia - E83.42; Hypertension, unspecified type - I10; Acute pancreatitis without infection or necrosis - K85.90; Lab test positive for detection of COVID-19 virus - U07.1; Nausea - R11.0; Pancreatitis, recurrent - K85.90",,amLODIPine 5 mg oral tablet,2,10/30/2021,1
10,,,6960201,1952-07-25,M,2021-10-12,Detected,"1.702 m (5' 7"")",61.4 kg (135 lb 5.8 oz),38.9 °C (102 °F),83,(!) 89,54,Never Smoker,,"PONV (postoperative nausea and vomiting)
Hodgkin lymphoma (HCC)
Heart attack (HCC)
Long COVID
Acute COVID-19
Systolic murmur
BPH with elevated PSA
Congestive heart failure, unspecified HF chronicity, unspecified heart failure type (HCC)
Renal failure
Atrial fibrillation, unspecified type (HCC)
Myocarditis (HCC)
Cardiac arrest (HCC)
Syncope and collapse","Systolic murmur [R01.1]
Dupuytren's contracture of left hand [M72.0]
BPH with elevated PSA [N40.0, R97.20]
Sepsis, due to unspecified organism, unspecified whether acute organ dysfunction present (HCC) [A41.9]
Pneumonia due to infectious organism, unspecified laterality, unspecified part of lung [J18.9]
Congestive heart failure, unspecified HF chronicity, unspecified heart failure type (HCC) [I50.9]
Renal failure [N19]
...","Systolic murmur - R01.1; BPH with elevated PSA - N40.0, R97.20; Congestive heart failure, unspecified HF chronicity, unspecified heart failure type (HCC) - I50.9; Renal failure - N19; Anemia - D64.9; Atrial fibrillation, unspecified type (HCC) - I48.91; Myocarditis (HCC) - I51.4; Stress hyperglycemia - R73.9; AKI (acute kidney injury) (HCC) - N17.9; Fever of unknown origin - R50.9; Tremor - R25.1; Lymphadenopathy of head and neck - R59.1; Chest pain - R07.9; Hodgkin lymphoma (HCC) - C81.90; Cardiac arrest (HCC) - I46.9; Blood transfusion abn reaction or complication, no procedure mishap - T80.92XA; On mechanically assisted ventilation (HCC) - Z99.11; Monoclonal B-cell lymphocytosis of undetermined significance - D72.820; Suspected COVID-19 virus infection - Z20.822; Infection due to 2019 novel coronavirus - U07.1; Vertigo - R42; Syncope and collapse - R55; Probable sepsis - R68.89; Severe sepsis (HCC) - A41.9, R65.20",50 to 55,There are too many medications to display. Please see the patient's chart for a complete list of medications.,4,11/7/2021,3
31,,,6023647,1946-07-26,F,2021-10-11,Detected,"1.6 m (5' 3"")",83.4 kg (183 lb 14.4 oz),37.2 °C (99 °F),60,141,(!) 55,Former Smoker,,"Symptomatic menopausal or female climacteric states
Type II or unspecified type diabetes mellitus without mention of complication, not stated as uncontrolled
HTN (hypertension)
Diabetic retinopathy (HCC)
Diabetes mellitus, type 2 (HCC)
Seizure (HCC)
Hyperlipemia
Meningioma (HCC)
Seizure (HCC)
Hemorrhagic diathesis (HCC)
Renal failure
Brain tumor (benign) (HCC)","Type II or unspecified type diabetes mellitus with ophthalmic manifestations, not stated as uncontrolled(250.50) (HCC) [E11.39]
Diabetic macular edema (HCC) [E11.311]
Diabetes mellitus with background retinopathy (HCC) [E11.3299]
Dry eye syndrome [H04.129]
Type 2 diabetes mellitus with both eyes affected by severe nonproliferative retinopathy without macular edema, with long-term current use of insulin (HCC) [E11.3493, Z79.4]
...","Dry eye syndrome - H04.129; Type 2 diabetes mellitus with both eyes affected by severe nonproliferative retinopathy without macular edema, with long-term current use of insulin (HCC) - E11.3493, Z79.4; Meningioma (HCC) - D32.9; Seizure (HCC) - R56.9; Diabetic polyneuropathy associated with type 2 diabetes mellitus (HCC) - E11.42; Diabetic nephropathy associated with type 2 diabetes mellitus (HCC) - E11.21; Mixed hyperlipidemia - E78.2; Benign essential HTN - I10; Pseudophakia, both eyes - Z96.1; Dry eyes - H04.123; Acute ischemic colitis (HCC) - K55.039; Chronic anemia - D64.9; Small intestinal bacterial overgrowth - K63.89; Anemia of chronic renal failure - N18.9, D63.1; Kidney disease, chronic, stage IV (GFR 15-29 ml/min) (HCC) - N18.4",,"amLODIPine 10 mg oral tablet; calcium carbonate/vitamin D3 (VITAMIN D-3 ORAL); DEXCOM G6 RECEIVER miscellaneous (misc) misc; DEXCOM G6 SENSOR miscellaneous (misc) device; DEXCOM G6 TRANSMITTER miscellaneous (misc) device; famotidine 20 mg oral tablet; FREESTYLE LITE STRIPS miscellaneous (misc) strip; furosemide 20 mg oral tablet; insulin glargine (LANTUS SOLOSTAR U-100 INSULIN) 100 unit/mL (3 mL) subcutaneous insulin pen; insulin lispro (HUMALOG KWIKPEN INSULIN) 100 unit/mL subcutaneous insulin pen; LEVETIRACETAM 500 mg oral tablet; lisinopriL 40 mg oral tablet; lovastatin 40 mg oral tablet; MELATONIN ORAL; metoprolol succinate 100 mg oral tablet extended release 24 hr; ondansetron ODT 4 mg oral tablet,disintegrating; ZINC ORAL",2,10/11/2021,1
34,,,7911265,1962-04-01,M,2021-10-11,Detected,1.829 m (6'),131.2 kg (289 lb 3.2 oz),37.2 °C (99 °F),80,143,78,Never Smoker,,"TIA (transient ischemic attack)
Knee pain, left
Atrial fibrillation (HCC)
Sleep apnea","HTN (hypertension), benign [I10]
Other hyperlipidemia [E78.49]
PAF (paroxysmal atrial fibrillation) (HCC) [I48.0]
TIA (transient ischemic attack) [G45.9]
OSA (obstructive sleep apnea) [G47.33]
Tinnitus [H93.19]
History of lip cancer [Z85.819]
Colon polyp [K63.5]
Prediabetes [R73.03]","HTN (hypertension), benign - I10; Other hyperlipidemia - E78.49; PAF (paroxysmal atrial fibrillation) (HCC) - I48.0; TIA (transient ischemic attack) - G45.9; OSA (obstructive sleep apnea) - G47.33; Tinnitus - H93.19; History of lip cancer - Z85.819; Colon polyp - K63.5; Prediabetes - R73.03",,albuterol 90 mcg/actuation inhalation HFA aerosol inhaler; amLODIPine 5 mg oral tablet; losartan (COZAAR) 100 mg oral tablet; MAGNESIUM ORAL; metoprolol succinate 50 mg oral tablet extended release 24 hr; rivaroxaban 20 mg oral tablet; rosuvastatin 5 mg oral tablet,1,10/15/2021,1
75,,,6936645,1946-03-17,F,2021-10-10,Detected,"1.651 m (5' 5"")",104.8 kg (231 lb),36.8 °C (98.2 °F),75,175,(!) 103,Never Smoker,,"Pregnancy
Pregnancy
Pregnancy
Pregnancy
Pregnancy
Hypertension
Diabetes (HCC)
Chicken pox
Congestive heart failure (HCC)
High cholesterol
Shortness of breath
GERD (gastroesophageal reflux disease)
Type 2 diabetes mellitus (HCC)
AV block
NSTEMI (non-ST elevated myocardial infarction) (HCC)","Shortness of breath [R06.02]
Actinic keratosis [L57.0]
Chronic diastolic heart failure (HCC) [I50.32]
Chronic kidney disease, stage III (moderate) (HCC) [N18.30]
Osteoarthritis [M19.90]
Complication of diabetes mellitus (HCC) [E11.8]
Diastolic dysfunction [I51.89]
Acute gastritis [K29.00]
Hyperlipidemia [E78.5]
BP (high blood pressure) [I10]
Osteoarthritis of knee [M17.10]
Restless legs syndrome [G25.81]
...","Actinic keratosis - L57.0; Chronic diastolic heart failure (HCC) - I50.32; Chronic kidney disease, stage III (moderate) (HCC) - N18.30; Osteoarthritis - M19.90; Complication of diabetes mellitus (HCC) - E11.8; Diastolic dysfunction - I51.89; Acute gastritis - K29.00; Hyperlipidemia - E78.5; BP (high blood pressure) - I10; Osteoarthritis of knee - M17.10; Restless legs syndrome - G25.81; NSVT (nonsustained ventricular tachycardia) (HCC) - I47.2; Chest tightness - R07.89; Uncontrolled hypertension - I10; Bilateral leg edema - R60.0; Vertigo - R42; Venous stasis - I87.8; Coronary artery disease involving native coronary artery of native heart - I25.10; Essential hypertension - I10; Presence of cardiac pacemaker - Z95.0; Aspiration pneumonia of right middle lobe due to gastric secretions (HCC) - J69.0; Acute pulmonary edema (HCC) - J81.0; SOB (shortness of breath) - R06.02; AV block, 2nd degree - I44.1; NSTEMI (non-ST elevated myocardial infarction) (HCC) - I21.4; Chest pain - R07.9; Chest pain, unspecified type - R07.9; Dementia with behavioral disturbance, unspecified dementia type (HCC) - F03.91; Morbid (severe) obesity due to excess calories (HCC) - E66.01",,There are too many medications to display. Please see the patient's chart for a complete list of medications.,3,11/8/2021,1
79,,,7462380,1983-03-01,M,2021-10-09,Detected,None,66.1 kg (145 lb 11.2 oz),36.4 °C (97.5 °F),90,127,78,Current Every Day Smoker,,,"Acute bronchopneumonia [J18.0]
Intracranial hemorrhage (HCC) [I62.9]
Laceration of scalp, initial encounter [S01.01XA]
Pedestrian injured in traffic accident involving motor vehicle, initial encounter [V09.20XA]","Acute bronchopneumonia - J18.0; Intracranial hemorrhage (HCC) - I62.9; Laceration of scalp, initial encounter - S01.01XA; Pedestrian injured in traffic accident involving motor vehicle, initial encounter - V09.20XA",,acetaminophen 500 mg oral tablet,11,10/16/2021,7
80,,,8179333,1954-02-02,M,2021-10-09,Detected,None,97.3 kg (214 lb 8.1 oz),36.9 °C (98.4 °F),67,138,61,Former Smoker,64.0,"Dementia (HCC)
Lung cancer metastatic to brain (HCC)
CVA (cerebral vascular accident) (HCC)
HTN (hypertension)
Seizure disorder (HCC)
A-fib (HCC)
CAD (coronary artery disease)","Multifocal pneumonia [J18.9]
Longstanding persistent atrial fibrillation (HCC) [I48.11]
Anticoagulated [Z79.01]
Dementia associated with other underlying disease with behavioral disturbance (HCC) [F02.81]
Lung cancer metastatic to brain (HCC) [C34.90, C79.31]
Chronic ischemic right anterior cerebral artery stroke [I69.30]
Dysarthria [R47.1]
History of seizures [Z87.898]
Transient alteration of awareness [R40.4]
...","Multifocal pneumonia - J18.9; Longstanding persistent atrial fibrillation (HCC) - I48.11; Anticoagulated - Z79.01; Dementia associated with other underlying disease with behavioral disturbance (HCC) - F02.81; Lung cancer metastatic to brain (HCC) - C34.90, C79.31; Chronic ischemic right anterior cerebral artery stroke - I69.30; Dysarthria - R47.1; History of seizures - Z87.898; Transient alteration of awareness - R40.4; Acute COVID-19 - U07.1; Toxic metabolic encephalopathy - G92.8; Encounter for monitoring anticonvulsant therapy - Z51.81, Z79.899",55 to 60,"acetaminophen 325 mg oral tablet; albuterol 90 mcg/actuation inhalation HFA aerosol inhaler; apixaban 5 mg oral tablet; artificial tears (dextran 70-hypromellose-glycerin) 0.1-0.3-0.2 % ophthalmic (eye) drops; atorvastatin 10 mg oral tablet; calcium carbonate chewable 200 mg calcium (500 mg) oral tablet,chewable; cholecalciferol (Vitamin D3) 1,000 unit oral tablet; citalopram 20 mg oral tablet; levETIRAcetam 1,000 mg oral tablet; Lidocaine 4 % topical adhesive patch,medicated; metoprolol tartrate 25 mg oral tablet; multivitamin oral tablet; omeprazole 20 mg oral capsule,delayed release(DR/EC); polyethylene glycol 17 gram oral powder in packet; senna 8.6 mg oral tablet",2,10/9/2021,1
88,,,852034,1962-01-26,F,2021-10-09,Detected,1.524 m (5'),106.6 kg (235 lb 0.2 oz),37 °C (98.6 °F),(!) 108,123,82,Former Smoker,,Diabetes (HCC),"Acute respiratory failure with hypoxia (HCC) [J96.01]
Suspected 2019 novel coronavirus infection [Z20.822]
Type 2 diabetes mellitus, without long-term current use of insulin (HCC) [E11.9]
Anxiety [F41.9]
SIRS (systemic inflammatory response syndrome) (HCC) [R65.10]
COVID [U07.1]
Depression [F32.A]
History of hysterectomy [Z90.710]
Polycythemia [D75.1]
...","Acute respiratory failure with hypoxia (HCC) - J96.01; Type 2 diabetes mellitus, without long-term current use of insulin (HCC) - E11.9; COVID - U07.1; Depression - F32.A; History of hysterectomy - Z90.710; Polycythemia - D75.1; Type 2 diabetes mellitus without complication, without long-term current use of insulin (HCC) - E11.9; Anemia - D64.9",,"Alcohol Swabs (ALCOHOL PREP SWABS) topical pads, medicated; atorvastatin 20 mg oral tablet; Blood Sugar Diagnostic (ONETOUCH ULTRA TEST) miscellaneous (misc) strip; buPROPion XL 150 mg oral tablet extended release 24 hr; CALCIUM 600 WITH VITAMIN D3 600 MG(1,500 MG)-400 UNIT CHEWABLE TABLET; insulin NPH 100 unit/mL subcutaneous suspension; lancets (ONE TOUCH DELICA) 33 gauge miscellaneous (misc) misc; lisinopriL 5 mg oral tablet; metFORMIN SR 500 mg oral tablet extended release 24 hr",2,10/23/2021,1
92,,,8177740,1990-05-22,F,2021-10-08,Detected,"1.77 m (5' 9.69"")",54.4 kg (120 lb),37 °C (98.6 °F),(!) 101,111,69,Never Smoker,,"Asthma
Bronchitis
Asthma",,,,"albuterol 90 mcg/actuation inhalation HFA aerosol inhaler; lidocaine 5 % topical adhesive patch,medicated",3,10/16/2021,1
99,,,6936158,1938-03-25,F,2021-10-08,Detected,"1.778 m (5' 10"")",72.6 kg (160 lb),36.4 °C (97.5 °F),83,130,76,Never Smoker,,"Plantar fasciitis
Foot pain
Acute pancreatitis
Skin cancer
Hyperlipidemia
Barrett's esophagus
Seizure disorder (HCC)
Diabetes (HCC)
Hypertension
Stage 2 chronic kidney disease","HLD (hyperlipidemia) [E78.5]
Climacteric [N95.1]
Acne erythematosa [L71.9]
Epilepsy (HCC) [G40.909]
Barrett's esophagus without dysplasia [K22.70]
Murmur, cardiac [R01.1]
Type 2 diabetes mellitus without complication (HCC) [E11.9]
Diastolic dysfunction [I51.89]
CKD (chronic kidney disease) stage 2, GFR 60-89 ml/min [N18.2]
Hypertension [I10]
Status epilepticus (HCC) [G40.901]
...","HLD (hyperlipidemia) - E78.5; Epilepsy (HCC) - G40.909; Barrett's esophagus without dysplasia - K22.70; Murmur, cardiac - R01.1; Type 2 diabetes mellitus without complication (HCC) - E11.9; Diastolic dysfunction - I51.89; CKD (chronic kidney disease) stage 2, GFR 60-89 ml/min - N18.2; Hypertension - I10; Cognitive dysfunction - F09; Difficulty walking - R26.2; Combined receptive and expressive aphasia due to acute cerebrovascular accident (CVA) (HCC) - I63.9, R47.01; Hyponatremia - E87.1; Seizure (HCC) - R56.9; SARS-CoV-2 positive - U07.1",,"ascorbic acid (vitamin C) (VITAMIN C) 500 mg oral tablet; aspirin EC 81 mg oral tablet,delayed release (DR/EC); atorvastatin (LIPITOR) 40 mg oral tablet; cholecalciferol, Vitamin D3, 1,000 unit oral capsule; docusate sodium (STOOL SOFTENER) 100 mg oral capsule; elderberry fruit (ELDERBERRY OR); Fish Oil-Omega-3 Fatty Acids 340-1,000 mg oral capsule; FLUTICASONE PROPIONATE 50 mcg/actuation nasal spray,suspension; folic acid 0.4 mg oral tablet; LEVETIRACETAM 1,000 mg oral tablet; melatonin 10 mg oral tablet,ext release multiphase; mirtazapine 30 mg oral tablet; nystatin 100,000 unit/gram topical powder; Psyllium Husk (FIBER THERAPY LAXATIVE (HUSK)) 0.52 gram oral capsule; sodium chloride 0.65 % nasal aerosol,spray",2,10/23/2021,1
109,,,6759133,1966-05-02,F,2021-10-08,Detected,"1.651 m (5' 5"")",65.8 kg (145 lb),36.5 °C (97.7 °F),70,110,88,Current Every Day Smoker,7.5,"PID (acute pelvic inflammatory disease)
Hypertension
Chronic airway obstruction (HCC)
GERD (gastroesophageal reflux disease)
Depressive disorder","TOA (tubo-ovarian abscess) [N70.93]
Pelvic pain [R10.2]
Infection due to 2019 novel coronavirus [U07.1]",TOA (tubo-ovarian abscess) - N70.93; Pelvic pain - R10.2; Infection due to 2019 novel coronavirus - U07.1,,"acetaminophen (TYLENOL) tablet 650 mg; azithromycin (AZITHROMYCIN (AKA Z-PAK)) 250 mg oral tablet; budesonide-formoteroL 160-4.5 mcg/actuation inhalation HFA aerosol inhaler; doxycycline hyclate 100 mg oral tablet; metroNIDAZOLE 500 mg oral tablet; omeprazole 20 mg oral capsule,delayed release(DR/EC); oxyCODONE (immediate release) 5 mg oral tablet",1,10/29/2021,1
120,,,6814620,1977-12-24,F,2021-10-08,Detected,"1.499 m (4' 11"")",100.7 kg (222 lb),36.8 °C (98.2 °F),64,100,60,Never Smoker,,"Cardiomyopathy (HCC)
Leukocytosis
Iron deficiency anemia
Achilles tendonitis
Depression
Headache
Congestive heart failure (HCC)
Arthropathy","Anemia [D64.9]
Disease of blood and blood forming organ [D75.9]
Cardiomyopathy (HCC) [I42.9]
CHF (NYHA class II, ACC/AHA stage C) (HCC) [I50.9]
Gastroesophageal reflux disease [K21.9]
Impaired fasting glucose [R73.01]
Morbid obesity due to excess calories (HCC) [E66.01]
Obstructive sleep apnea syndrome [G47.33]
Cystitis [N30.90]
Cystocele, lateral [N81.12]
Thrombocythemia [D75.839]
...","Anemia - D64.9; Disease of blood and blood forming organ - D75.9; Cardiomyopathy (HCC) - I42.9; CHF (NYHA class II, ACC/AHA stage C) (HCC) - I50.9; Gastroesophageal reflux disease - K21.9; Impaired fasting glucose - R73.01; Morbid obesity due to excess calories (HCC) - E66.01; Obstructive sleep apnea syndrome - G47.33; Cystitis - N30.90; Cystocele, lateral - N81.12; Thrombocythemia - D75.839; Mixed stress and urge urinary incontinence - N39.46; Recurrent UTI - N39.0; PID (acute pelvic inflammatory disease) - N73.0; Noncompliance with CPAP treatment - Z91.14; Menorrhagia - N92.0; IUD (intrauterine device) in place - Z97.5; Incomplete uterovaginal prolapse - N81.2; Hydrosalpinx - N70.11; Depression - F32.A",45 to 50,"albuterol 90 mcg/actuation inhalation HFA aerosol inhaler; benzonatate 100 mg oral capsule; carvediloL 6.25 mg oral tablet; fluticasone propionate (FLOVENT HFA) 44 mcg/actuation inhalation HFA aerosol inhaler; FUROSEMIDE 20 mg oral tablet; ibuprofen 200 mg oral tablet; lisinopril 2.5 mg oral tablet; loratadine 10 mg oral tablet; nystatin 100,000 unit/gram topical powder; OMEPRAZOLE 40 mg oral capsule,delayed release(DR/EC); ondansetron ODT 4 mg oral tablet,disintegrating; spironolactone 25 mg oral tablet; trospium 20 mg oral tablet; venlafaxine 75 mg oral tablet",1,,1
157,,,2011286,1972-07-06,F,2021-10-07,Detected,"1.626 m (5' 4"")",81.6 kg (180 lb),37 °C (98.6 °F),77,137,78,Light Tobacco Smoker,,"Fibromyalgia
Depression
PTSD (post-traumatic stress disorder)
ADHD (attention deficit hyperactivity disorder)","Insomnia [G47.00]
Major depressive disorder [F32.9]
Methamphetamine dependence (HCC) [F15.20]
Tobacco use disorder [F17.200]",Insomnia - G47.00; Major depressive disorder - F32.9; Methamphetamine dependence (HCC) - F15.20; Tobacco use disorder - F17.200,,"CYANOCOBALAMIN, VITAMIN B-12, ORAL; cyclobenzaprine 5 mg oral tablet; gabapentin 300 mg oral capsule; ibuprofen 200 mg oral tablet; ondansetron ODT 4 mg oral tablet,disintegrating; prenatal vitamins (with calcium) iron-folic acid 27 mg iron- 1 mg oral tablet",3,10/7/2021,1
178,,,8175173,1962-09-30,F,2021-10-06,Detected,None,None,37.1 °C (98.8 °F),72,125,81,Current Every Day Smoker,,Arthritis,,,,"cetirizine 10 mg oral tablet; oxymetazoline 0.05 % nasal spray,non-aerosol",2,10/13/2021,1
189,,,6621524,1930-07-05,F,2021-10-06,Detected,None,None,37.3 °C (99.1 °F),97,142,92,Former Smoker,,"Rheumatic fever
Fibromyalgia
Scarlet fever
Arthritis
Tuberculosis
Rift Valley fever
Glaucoma
Cataract",,,,ALBUTEROL INHL; ALPRAZOLAM (XANAX ORAL); clopidogrel (PLAVIX) 75 mg oral tablet; fluticasone-salmeterol (ADVAIR DISKUS) 250-50 mcg/dose inhalation Disk with Device; levothyroxine 25 mcg oral tablet; metoprolol succinate 50 mg oral tablet extended release 24 hr; OMEPRAZOLE ORAL; POTASSIUM CHLORIDE (KLOR-CON M20 ORAL); sertraline 50 mg oral tablet; simvastatin 20 mg oral tablet; timolol 0.5 % ophthalmic Drops; triamterene-hydrochlorothiazide (MAXZIDE) 75-50 mg oral tablet,2,10/6/2021,1
200,,,7034503,1958-07-03,M,2021-10-06,Detected,"1.803 m (5' 11"")",72.6 kg (160 lb),37.2 °C (99 °F),88,114,82,Never Smoker,,"Essential hypertension
Rheumatoid arthritis (HCC)
Hyperlipidemia
GERD (gastroesophageal reflux disease)",Tubular adenoma of colon [D12.6],Tubular adenoma of colon - D12.6,,"dextromethorphan-guaiFENesin 10-100 mg/5 mL oral syrup; lisinopril 5 mg oral tablet; loperamide 2 mg oral capsule; omeprazole 10 mg oral capsule,delayed release(DR/EC); ondansetron ODT 4 mg oral tablet,disintegrating; predniSONE 5 mg oral tablet",2,10/6/2021,1
280,,,6436315,2001-07-17,F,2021-10-04,Detected,"1.702 m (5' 7"")",72.6 kg (160 lb),36.7 °C (98.1 °F),79,111,68,Never Smoker,,"Kidney stone
Muscle weakness (generalized)
Charcot-Marie-Tooth disease","Kidney stone [N20.0]
Slipped capital femoral epiphysis [M93.003]
Hip pain, left [M25.552]
Charcot-Marie-Tooth disease [G60.0]
Retained orthopedic hardware [Z96.9]","Kidney stone - N20.0; Slipped capital femoral epiphysis - M93.003; Hip pain, left - M25.552; Charcot-Marie-Tooth disease - G60.0; Retained orthopedic hardware - Z96.9",,"aspirin EC 325 mg oral tablet,delayed release (DR/EC); diazePAM 5 mg oral tablet; ferrous sulfate (IRON) 325 mg total salt (65 mg elemental) oral tablet; gabapentin 300 mg oral capsule; gabapentin 300 mg oral capsule; ibuprofen 200 mg oral tablet; naproxen 500 mg oral tablet; norgestimate-ethinyl estradiol 0.18/0.215/0.25 mg-25 mcg oral tablet; oxyCODONE (immediate release) 5 mg oral tablet; oxyCODONE (immediate release) 5 mg oral tablet; oxyCODONE (immediate release) 5 mg oral tablet; oxyCODONE (immediate release) 5 mg oral tablet; senna-docusate (SENNA-S) 8.6-50 mg oral tablet",1,,1
302,,,7458177,2006-09-21,F,2021-10-04,Detected,"157.5 cm (5' 2"")",86 kg (189 lb 8 oz),36.9 °C (98.4 °F),100,100,72,Never Smoker,,"Headache
Anxiety
Depression","Depression [F32.A]
Foster child [Z62.21]
Scar of forehead [L90.5]
Dental caries [K02.9]
Child previously sexually abused [Z62.810]
Patellar instability of right knee [M25.361]",Depression - F32.A; Foster child - Z62.21; Scar of forehead - L90.5; Dental caries - K02.9; Child previously sexually abused - Z62.810; Patellar instability of right knee - M25.361,,escitalopram oxalate 10 mg oral tablet; hydrOXYzine 25 mg oral tablet; ibuprofen 200 mg oral tablet; Melatonin 5 mg oral capsule,1,,1
312,,,6529908,1986-08-19,F,2021-10-04,Detected,"1.651 m (5' 5"")",127.4 kg (280 lb 13.9 oz),36.4 °C (97.5 °F),97,106,76,Former Smoker,5.0,"Anemia
Depression
Malignant neoplasm (HCC)
BRCA1 gene mutation positive
Breast cancer (HCC)
Anxiety state
Hypertension
GERD (gastroesophageal reflux disease)","Triple negative malignant neoplasm of breast (HCC) [C50.919]
Dehydration [E86.0]
BRCA1-associated protein-1 tumor predisposition syndrome [Z15.01, Z15.09, Z15.02]
Chemotherapy induced neutropenia (HCC) [D70.1, T45.1X5A]
Malignant neoplasm of lower-outer quadrant of right breast of female, estrogen receptor negative (HCC) [C50.511, Z17.1]
BRCA1 positive [Z15.01, Z15.09]
Closed fracture of metatarsal bone [S92.309A]
...","Triple negative malignant neoplasm of breast (HCC) - C50.919; Dehydration - E86.0; BRCA1-associated protein-1 tumor predisposition syndrome - Z15.01, Z15.09, Z15.02; Chemotherapy induced neutropenia (HCC) - D70.1, T45.1X5A; Malignant neoplasm of lower-outer quadrant of right breast of female, estrogen receptor negative (HCC) - C50.511, Z17.1; BRCA1 positive - Z15.01, Z15.09; Closed fracture of metatarsal bone - S92.309A; Dichorionic diamniotic twin pregnancy in third trimester - O30.043; Dysplasia of cervix, low grade (CIN 1) - N87.0; Gestational hypertension - O13.9; HGSIL on cytologic smear of cervix - R87.613; Lump of right breast - N63.10; NSVD (normal spontaneous vaginal delivery) - O80; Morbid (severe) obesity due to excess calories (HCC) - E66.01; Other psychological or physical stress, not elsewhere classified(V62.89) - Z73.3; Tinea - B35.9; RSV infection - B97.4; Positive GBS test - B95.1; PMDD (premenstrual dysphoric disorder) - F32.81; Twin pregnancy, twins discordant in third trimester - O30.003, O36.5930; Well woman exam with routine gynecological exam - Z01.419; Vaginal discharge - N89.8",,calcium carbonate (TUMS ORAL); cannabidioL 100 mg/mL oral solution,1,4/10/2021,1
372,,,8170443,1929-04-08,F,2021-09-30,Detected,None,None,None,None,None,None,Never Assessed,,,,,,,2,,1
398,,,519982,1947-09-27,M,2021-09-30,Detected,None,None,36.9 °C (98.5 °F),67,147,(!) 120,Never Smoker,,"Malignant melanoma nos
Ear problems
Blood transfusion
Pneumonia
Kidney stones
Osteoarthritis","Blepharitis [H01.009]
Iris nevus [D31.40]
Amblyopia [H53.009]
Esotropia
Hyperopia [H52.00]
Rotator cuff rupture
Shoulder arthritis [M19.019]
Actinic keratosis [L57.0]
Personal history of malignant melanoma of skin [Z85.820]
Other seborrheic keratosis [L82.1]
Rash and other nonspecific skin eruption [R21]",Blepharitis - H01.009; Iris nevus - D31.40; Hyperopia - H52.00; Shoulder arthritis - M19.019; Actinic keratosis - L57.0; Personal history of malignant melanoma of skin - Z85.820; Other seborrheic keratosis - L82.1; Rash and other nonspecific skin eruption - R21,,aspirin 325 mg oral tablet; codeine-guaiFENesin 10-100 mg/5 mL oral liquid; Ibuprofen 800 mg OR TABS; lisinopril 20 mg oral tablet,1,,1
404,,,6826732,1998-09-10,F,2021-09-30,Detected,"1.6 m (5' 2.99"")",60.3 kg (133 lb),36.8 °C (98.2 °F),74,101,55,Never Smoker,,"Chorioamnionitis in third trimester
Fetal cardiac echogenic focus, antepartum, fetus 1
GBS carrier
Vaginal delivery","Encounter for supervision of normal first pregnancy in third trimester [Z34.03]
Fetal cardiac echogenic focus, antepartum, fetus 1 [O35.8XX1]
GBS carrier [Z22.330]
Vaginal delivery [O80]
Single live birth [Z37.0]
Chorioamnionitis in third trimester [O41.1230]
Preventative health care [Z00.00]
IUD threads lost [T83.32XA]",Preventative health care - Z00.00; IUD threads lost - T83.32XA,,cephALEXin 500 mg oral capsule; prenatal vitamins (with calcium) iron-folic acid 27 mg iron- 1 mg oral tablet,1,11/4/2021,1
406,,,6978978,1998-07-23,F,2021-09-30,Detected,"1.676 m (5' 5.98"")",92.1 kg (203 lb),37 °C (98.6 °F),105,93,49,Never Smoker,,"Ehlers-Danlos syndrome
Hidradenitis suppurativa","Ehlers-Danlos syndrome [Q79.60]
Blood type, Rh negative [Z67.91]
Low-lying placenta [O44.40]
High-risk pregnancy, third trimester [O09.93]
ASD (atrial septal defect) [Q21.1]
Lymphedema [I89.0]
Gestational HTN, third trimester [O13.3]
Encounter for Nexplanon removal [Z30.46]
Hidradenitis suppurativa [L73.2]","Ehlers-Danlos syndrome - Q79.60; High-risk pregnancy, third trimester - O09.93; ASD (atrial septal defect) - Q21.1; Lymphedema - I89.0; Encounter for Nexplanon removal - Z30.46; Hidradenitis suppurativa - L73.2",,"albuterol 90 mcg/actuation inhalation HFA aerosol inhaler; dextromethorphan-guaiFENesin 60-1,200 mg oral tablet extended release 12 hr",1,,1
442,,,7565059,1975-05-23,M,2021-09-29,Detected,"1.651 m (5' 5"")",55.4 kg (122 lb 2.2 oz),38.2 °C (100.8 °F),122,120,69,Never Smoker,,"DM (diabetes mellitus) (HCC)
HTN (hypertension)","Diabetic ulcer of left great toe (HCC) [E11.621, L97.529]
Cellulitis, unspecified cellulitis site [L03.90]
Sepsis (HCC) [A41.9]
Osteomyelitis of left foot (HCC) [M86.9]
Acute osteomyelitis of toe, left (HCC) [M86.172]
Respiratory failure with hypoxia (HCC) [J96.91]
Pneumonia due to 2019 novel coronavirus [U07.1, J12.82]
Essential hypertension [I10]
Hypoxemia [R09.02]
Generalized weakness [R53.1]
Dyspnea on exertion [R06.00]
...","Diabetic ulcer of left great toe (HCC) - E11.621, L97.529; Cellulitis, unspecified cellulitis site - L03.90; Sepsis (HCC) - A41.9; Osteomyelitis of left foot (HCC) - M86.9; Acute osteomyelitis of toe, left (HCC) - M86.172; Respiratory failure with hypoxia (HCC) - J96.91; Pneumonia due to 2019 novel coronavirus - U07.1, J12.82; Essential hypertension - I10; Hypoxemia - R09.02; Generalized weakness - R53.1; Dyspnea on exertion - R06.00; Pneumonia - J18.9",,"acetaminophen 325 mg oral tablet; amLODIPine 10 mg oral tablet; ascorbic acid (vitamin C) 500 mg oral tablet; aspirin chewable 81 mg oral tablet,chewable; atorvastatin 20 mg oral tablet; benzonatate 100 mg oral capsule; ergocalciferol 50,000 unit oral capsule; ferrous gluconate 324 mg (38 mg iron) oral tablet; glipiZIDE 5 mg oral tablet; insulin detemir U-100 (LEVEMIR FLEXTOUCH U-100 INSULN) 100 unit/mL (3 mL) subcutaneous insulin pen; lisinopriL 20 mg oral tablet; sodium chloride 0.65 % nasal aerosol,spray",4,10/4/2021,1
454,,,6249307,2009-08-22,M,2021-09-29,Detected,"158 cm (5' 2.21"")",60.1 kg (132 lb 7.9 oz),36.7 °C (98.1 °F),75,114,86,Never Smoker,,"Delayed speech
Broken arm
FB bronchus
Migraine
Hearing impaired
Lab test positive for detection of COVID-19 virus","Conductive hearing loss, bilateral [H90.0]
Concussion with loss of consciousness, initial encounter [S06.0X9A]","Conductive hearing loss, bilateral - H90.0; Concussion with loss of consciousness, initial encounter - S06.0X9A",,"acetaminophen 500 mg oral tablet; diphenhydrAMINE 25 mg oral capsule; naproxen 500 mg oral tablet; ondansetron ODT 4 mg oral tablet,disintegrating; rizatriptan rapid dissolve 5 mg oral tablet,disintegrating",2,11/4/2021,1
529,,,6960763,1997-08-22,F,2021-09-27,Detected,"1.676 m (5' 6"")",100.2 kg (221 lb),36.8 °C (98.3 °F),94,118,66,Never Smoker,,,"Encounter for supervision of normal first pregnancy in third trimester [Z34.03]
Late prenatal care [O09.30]
Supervision of normal pregnancy in third trimester [Z34.93]
Maternal care for fetal problem in third trimester [O36.93X0]
Pregnancy complicated by fetal abdominal mass [O35.8XX0]
Known fetal anomaly, antepartum [O35.9XX0]
Pregnant and not yet delivered in third trimester [Z34.93]
...",,,"acetaminophen 325 mg oral tablet; fentaNYL citrate (PF) (SUBLIMAZE) syringe 25-150 mcg; flumazeniL (ROMAZICON) injection 0.2-0.3 mg; ibuprofen 600 mg oral tablet; ketamine in NaCl, iso-osmotic (KETALAR) injection 20-200 mg; midazolam (VERSED) injection 1-10 mg; naloxone (NARCAN) injection 0.2-0.4 mg; norethindrone-ethinyl estradiol (LOESTRIN 1/20 (21)) 1-20 mg-mcg oral tablet; omeprazole 20 mg oral capsule,delayed release(DR/EC); ondansetron (ZOFRAN) injection 4-8 mg; ondansetron 4 mg oral tablet; ondansetron ODT (ZOFRAN ODT) tablet 4-8 mg; ondansetron ODT 4 mg oral tablet,disintegrating; simethicone (MYLICON) suspension 3.333 mg; sodium chloride (NS) 0.9 % infusion",3,11/6/2021,2
584,,,8167610,1977-03-28,M,2021-09-26,Detected,None,None,36.7 °C (98.1 °F),90,105,(!) 59,Current Some Day Smoker,,Known health problems: none,,,,"acetaminophen 500 mg oral tablet; ibuprofen 600 mg oral tablet; lidocaine 5 % topical adhesive patch,medicated; naproxen 500 mg oral tablet",2,11/4/2021,1
699,,,8166029,1990-10-01,M,2021-09-25,Detected,"1.88 m (6' 2"")",83 kg (182 lb 15.7 oz),36.8 °C (98.2 °F),99,118,69,Current Every Day Smoker,,,"Cellulitis of left upper extremity [L03.114]
Sepsis, due to unspecified organism, unspecified whether acute organ dysfunction present (HCC) [A41.9]
Abscess of left arm [L02.414]",Abscess of left arm - L02.414,,,3,11/9/2021,2
773,,,6234549,1944-10-19,F,2021-09-21,Detected,"1.626 m (5' 4"")",108 kg (238 lb),35.9 °C (96.6 °F),138,98,51,Former Smoker,25.0,"Fibromyalgia muscle pain
Severe aortic stenosis
HTN (hypertension)
Hypercholesterolemia
Morbid obesity (HCC)
Pulmonary HTN (HCC)
Diabetes mellitus (HCC)
Chronic diastolic congestive heart failure (HCC)
Sleep apnea
Spondylolisthesis
Fibromyalgia
Depression
Disorder of thyroid
Type 2 diabetes mellitus (HCC)","Lumbosacral radiculopathy [M54.17]
Spondylolisthesis [M43.10]
Fibromyalgia [M79.7]
Morbid obesity due to excess calories (HCC) [E66.01]
Anaclitic depression [F43.20]
Fibromyalgia muscle pain [M79.7]
History of aortic valve stenosis [Z86.79]
Essential hypertension [I10]
Mixed hyperlipidemia [E78.2]
Pulmonary hypertension (HCC) [I27.20]
Type 2 diabetes mellitus with diabetic neuropathy (HCC) [E11.40]
...","Lumbosacral radiculopathy - M54.17; Fibromyalgia - M79.7; Morbid obesity due to excess calories (HCC) - E66.01; Anaclitic depression - F43.20; History of aortic valve stenosis - Z86.79; Essential hypertension - I10; Mixed hyperlipidemia - E78.2; Pulmonary hypertension (HCC) - I27.20; Type 2 diabetes mellitus with diabetic neuropathy (HCC) - E11.40; Obstructive sleep apnea syndrome - G47.33; Perennial allergic rhinitis - J30.89; Insomnia - G47.00; Chronic diastolic heart failure (HCC) - I50.32; Obesity hypoventilation syndrome (HCC) - E66.2; Actinic keratosis - L57.0; Adrenal adenoma - D35.00; Vitamin D deficiency - E55.9; Hypothyroidism (acquired) - E03.9; Family history of malignant neoplasm of gastrointestinal tract - Z80.0; Presbycusis - H91.10; Vitamin B12 deficiency - E53.8; Tubular adenoma of colon - D12.6; Leukocytosis - D72.829; Diabetic nephropathy associated with type 2 diabetes mellitus (HCC) - E11.21; Allergy to intravenous contrast media - Z91.041; Chronic pain - G89.29; Nocturia - R35.1; Osteoarthritis of hand - M19.049; S/P TAVR (transcatheter aortic valve replacement) - Z95.2; Atypical ductal hyperplasia of breast - N60.99; Osteoporosis of multiple sites - M81.0; Anemia of unknown etiology - D64.9; Mediastinal lymphadenopathy - R59.0; Diabetic retinopathy associated with type 2 diabetes mellitus (HCC) - E11.319; Dyspepsia - R10.13; Proctitis - K62.89; Constipation, unspecified constipation type - K59.00; Leukocytosis, unspecified type - D72.829; High anion ...",,"acetaminophen 325 mg oral tablet; amLODIPine 10 mg oral tablet; Bacitracin zinc 500 unit/gram topical ointment in packet; cyanocobalamin (VITAMIN B-12) 500 mcg oral tablet; ergocalciferol 50,000 unit oral capsule; famotidine 20 mg oral tablet; GABAPENTIN 300 mg oral capsule; hydrocortisone 2.5 % topical cream; insulin NPH 100 unit/mL subcutaneous suspension; Insulin Regular Human 100 unit/mL (3 mL) subcutaneous insulin pen; levothyroxine 137 mcg oral tablet; lisinopril 40 mg oral tablet; ONETOUCH VERIO TEST STRIPS miscellaneous (misc) strip; polyethylene glycol 17 gram oral powder in packet; pravastatin 40 mg oral tablet; traZODone 100 mg oral tablet",2,11/3/2021,2
780,,,1411412,1985-03-20,F,2021-09-21,Detected,"1.676 m (5' 6"")",80.7 kg (178 lb),36.9 °C (98.4 °F),99,118,83,Current Every Day Smoker,7.0,"Genital HSV
Obesity
Chickenpox
Anxiety
Heartburn","History of cesarean section [Z98.891]
History of infectious disease [Z86.19]
Herpes simplex virus (HSV) infection [B00.9]
Methadone dependence (HCC) [F11.20]
Obesity affecting pregnancy, antepartum [O99.210]
Opioid dependence in remission (HCC) [F11.21]
Pregnancy [Z34.90]
Tobacco use [Z72.0]
Status post repeat low transverse cesarean section [Z98.891]
Delivered by cesarean section [Z38.01]
Cocaine abuse (HCC) [F14.10]
...",History of infectious disease - Z86.19; Herpes simplex virus (HSV) infection - B00.9; Methadone dependence (HCC) - F11.20; Opioid dependence in remission (HCC) - F11.21; Tobacco use - Z72.0; Status post repeat low transverse cesarean section - Z98.891; Delivered by cesarean section - Z38.01; Cocaine abuse (HCC) - F14.10; Thrombocytopenia (HCC) - D69.6,,"acetaminophen 325 mg oral tablet; docusate sodium 100 mg oral capsule; docusate sodium 100 mg oral capsule; doxycycline monohydrate 100 mg oral capsule; ferrous sulfate 325 mg total salt (65 mg elemental) oral tablet; hydrOXYzine pamoate 25 mg oral capsule; ibuprofen 600 mg oral tablet; ibuprofen 600 mg oral tablet; lidocaine 5 % topical adhesive patch,medicated; methadone 10 mg/5 mL oral solution; oxyCODONE, immediate release, 10 mg oral tablet; polyethylene glycol 17 gram/dose oral powder; ranitidine 150 mg oral tablet",5,11/6/2021,2
860,,,6447241,2011-11-01,F,2021-09-20,Detected,"141.1 cm (4' 7.55"")",41.6 kg (91 lb 11.2 oz),36.9 °C (98.4 °F),76,109,71,Never Smoker,,,"Normal newborn (single liveborn) [Z38.2]
Persistent disorder of initiating or maintaining sleep [G47.00]
Otitis media in pediatric patient [H66.90]
Primary nocturnal enuresis [N39.44]
Strep throat [J02.0]
Anxiety disorder of childhood [F93.8]
Concussion with no loss of consciousness [S06.0X0A]
ADHD [F90.9]
Infection due to 2019 novel coronavirus [U07.1]",Normal newborn (single liveborn) - Z38.2; Persistent disorder of initiating or maintaining sleep - G47.00; Otitis media in pediatric patient - H66.90; Primary nocturnal enuresis - N39.44; Strep throat - J02.0; Anxiety disorder of childhood - F93.8; Concussion with no loss of consciousness - S06.0X0A; ADHD - F90.9; Infection due to 2019 novel coronavirus - U07.1,,"desmopressin (DDAVP) 0.1 mg oral tablet; FLUoxetine 10 mg oral capsule; FLUoxetine 10 mg oral capsule; FLUoxetine 20 mg oral capsule; FLUoxetine 20 mg oral capsule; FLUoxetine 20 mg oral capsule; methylphenidate ER 24 hour 18 mg oral tablet extended release 24hr; methylphenidate ER 24 hour 18 mg oral tablet extended release 24hr; methylphenidate ER 24 hour 18 mg oral tablet extended release 24hr; pediatric multivitamin chewable (FLINTSTONES MULTIVITAMIN) oral tablet,chewable",1,10/16/2021,1
950,,,6727559,1969-10-31,M,2021-09-16,Detected,None,None,37.5 °C (99.5 °F),96,114,79,Current Every Day Smoker,,,,,,,2,,1
969,,,6340380,1944-10-20,M,2021-09-16,Detected,"1.854 m (6' 1"")",132.7 kg (292 lb 8 oz),36.5 °C (97.7 °F),96,127,63,Former Smoker,6.0,"Chronic diastolic HF (heart failure), NYHA class 3 (HCC)
Dyslipidemia
Atrial fibrillation (HCC)
CKD (chronic kidney disease)
Hypertension
Anemia of chronic kidney failure
Hyperlipidemia
Type 2 diabetes mellitus (HCC)
Hearing loss
Elevated troponin
Congestive heart failure (HCC)
Arrhythmia
Encounter for extracorporeal dialysis (HCC)
Pneumonia due to organism
Shortness of breath
Heart attack (HCC)","Acute on chronic renal failure (HCC) [N17.9, N18.9]
CHF (congestive heart failure), NYHA class IV (HCC) [I50.9]
DM type 2 causing CKD stage 4 (HCC) [E11.22, N18.4]
DM type 2 causing CKD stage 4 (HCC) [E11.22, N18.4]
CHF (NYHA class IV, ACC/AHA stage D) (HCC) [I50.9]
Chronic systolic heart failure (HCC) [I50.22]
Bradycardia, drug induced [R00.1, T50.905A]
Hypotension due to drugs [I95.2]
...","CHF (NYHA class IV, ACC/AHA stage D) (HCC) - I50.84; Chronic systolic heart failure (HCC) - I50.22; Type 2 diabetes, uncontrolled, with renal manifestation (HCC) - E11.29, E11.65; Atrial fibrillation (HCC) - I48.91; Anticoagulated on warfarin - Z79.01; Hypertension - I10; Anemia in other chronic diseases classified elsewhere - D63.8; Morbid obesity with BMI of 40.0-44.9, adult (HCC) - E66.01, Z68.41; Hyperkalemia - E87.5; Orthostasis - I95.1; Elevated troponin - R77.8; Diarrhea - R19.7; Dehydration - E86.0; Diarrhea, unspecified type - R19.7; CKD (chronic kidney disease) stage 5, GFR less than 15 ml/min (HCC) - N18.5; Aspiration into airway, initial encounter - T17.908A; Hypernatremia - E87.0; Pneumonia of left lower lobe due to infectious organism - J18.9; Permanent atrial fibrillation (HCC) - I48.21; Acute kidney injury (HCC) - N17.9; Congestive heart failure, unspecified HF chronicity, unspecified heart failure type (HCC) - I50.9; Stage 5 chronic kidney disease not on chronic dialysis (HCC) - N18.5; 2019 novel coronavirus disease (COVID-19) - U07.1; Acute on chronic anemia - D64.9; Weakness - R53.1",,There are too many medications to display. Please see the patient's chart for a complete list of medications.,2,10/22/2021,1
985,,,564447,1975-11-06,F,2021-09-16,Detected,"1.66 m (5' 5.35"")",60.9 kg (134 lb 4.2 oz),36.2 °C (97.2 °F),90,104,66,Former Smoker,0.2,"Lupus (systemic lupus erythematosus) (HCC)
Hypertension
Lupus nephritis (HCC)
Antiphospholipid antibody syndrome (HCC)
History of Cytoxan exposure
Sleep apnea
Irritable bowel syndrome
Anxiety state
Hemorrhagic diathesis (HCC)
Congestive heart failure (HCC)
Renal failure","Renal failure [N19]
WPW (Wolff-Parkinson-White syndrome) [I45.6]
Kidney transplanted [Z94.0]
Immunosuppressive management encounter following kidney transplant [Z79.899, Z94.0]
Abnormal coagulation profile [R79.1]
Other pulmonary embolism and infarction [I26.99]
DVT of lower extremity (deep venous thrombosis) (HCC) [I82.409]
Hypomagnesemia [E83.42]
Hypophosphatemia [E83.39]
Prophylactic antibiotic [Z79.2]
...","WPW (Wolff-Parkinson-White syndrome) - I45.6; Kidney transplanted - Z94.0; Immunosuppressive management encounter following kidney transplant - Z79.899, Z94.0; History of antiphospholipid antibody syndrome - Z86.2; Long term current use of anticoagulant therapy - Z79.01; Metabolic bone disease - E88.9, M90.80; Essential hypertension, benign - I10; SLE (systemic lupus erythematosus) (HCC) - M32.9; GERD (gastroesophageal reflux disease) - K21.9; Kidney transplant rejection - T86.11; Hyperuricemia - E79.0; Health maintenance examination - Z00.00; History of Cytoxan exposure - Z92.21; Proteinuria - R80.9; Acidemia - E87.2; Cervical dysplasia - N87.9; CIN III (cervical intraepithelial neoplasia III) - D06.9; VIN III (vulvar intraepithelial neoplasia III) - D07.1; Vaginal bleeding - N93.9; Acute hypoxemic respiratory failure (HCC) - J96.01; Volume overload - E87.70; AKI (acute kidney injury) (HCC) - N17.9; Acute gout due to renal impairment involving toe of left foot - M10.372; Heart failure with preserved ejection fraction (HCC) - I50.30; Neck swelling - R22.1; Cervical intraepithelial neoplasm - N87.9; ARDS (adult respiratory distress syndrome) (HCC) - J80; Pneumonia due to COVID-19 virus - U07.1, J12.82; At risk for malnutrition - Z91.89; Atrial fibrillation with RVR (HCC) - I48.91; Heart failure with acute decompensation, type unknown (HCC) - I50.9; Anemia - D64.9; Anxiety state - F41.1; Pain - R52; Hemorrhagic shock (HCC) - R57.8; Hematoma of bladder wall - S37.22XA; Bladde...",65 to 70,There are too many medications to display. Please see the patient's chart for a complete list of medications.,2,,1
1008,,,7881368,1993-02-02,F,2021-09-15,Detected,"1.651 m (5' 5"")",121.6 kg (268 lb),37.2 °C (99 °F),87,112,68,Never Smoker,,,"GAD (generalized anxiety disorder) [F41.1]
ADHD, predominantly inattentive type [F90.0]","GAD (generalized anxiety disorder) - F41.1; ADHD, predominantly inattentive type - F90.0",,dextroamphetamine-amphetamine (ADDERALL) 15 mg oral tablet,1,10/25/2021,1
1034,,,1110919,1954-12-06,F,2021-09-15,Detected,"1.702 m (5' 7"")",106.4 kg (234 lb 8 oz),36.9 °C (98.5 °F),85,124,72,Former Smoker,36.0,"History of Bell's palsy
Coronary artery disease
Aortic stenosis
Carotid artery disease (HCC)
CKD (chronic kidney disease) stage 3, GFR 30-59 ml/min (HCC)
Asthma
Chronic urticaria
Essential hypertension
History of tobacco abuse
History of methamphetamine abuse (HCC)
Pacemaker","Severe aortic stenosis [I35.0]
CAD (coronary artery disease) [I25.10]
Hypertension [I10]
Hyperlipidemia [E78.5]
Tobacco abuse [Z72.0]
Methamphetamine use (HCC) [F15.10]
Asthma [J45.909]
Carotid stenosis [I65.29]
History of tobacco abuse [Z87.891]
History of methamphetamine abuse (HCC) [F15.11]
History of Bell's palsy [Z86.69]
Essential hypertension [I10]
Coronary artery disease [I25.10]
...","Severe aortic stenosis - I35.0; CAD (coronary artery disease) - I25.10; Hypertension - I10; Hyperlipidemia - E78.5; Tobacco abuse - Z72.0; Methamphetamine use (HCC) - F15.10; Asthma - J45.909; Carotid stenosis - I65.29; History of tobacco abuse - Z87.891; History of methamphetamine abuse (HCC) - F15.11; History of Bell's palsy - Z86.69; Essential hypertension - I10; Coronary artery disease - I25.10; CKD (chronic kidney disease) stage 3, GFR 30-59 ml/min (HCC) - N18.30; Chronic urticaria - L50.8; Carotid artery disease (HCC) - I77.9; Aortic stenosis - I35.0; Aortic stenosis, severe - I35.0; Nonrheumatic mitral valve stenosis - I34.2; Coronary artery disease of native artery of native heart with stable angina pectoris (HCC) - I25.118; CKD (chronic kidney disease) stage 3, GFR 30-59 ml/min (HCC) - N18.30; Hyperlipidemia - E78.5; Benign essential hypertension - I10; S/P TAVR (transcatheter aortic valve replacement) - Z95.2; Moderate aortic stenosis - I35.0; COPD (chronic obstructive pulmonary disease) (HCC) - J44.9; Chronic diastolic congestive heart failure (HCC) - I50.32; Chronic renal insufficiency, stage 4 (severe) (HCC) - N18.4; Disorder of adrenal gland, unspecified (HCC) - E27.9; Long term (current) use of systemic steroids - Z79.52; Angio-edema - T78.3XXA; Chronic dermatitis - L30.9; Complete heart block (HCC) - I44.2; Heart block - I45.9; Acute COVID-19 - U07.1; Heart failure with preserved ejection fraction (HCC) - I50.30; Antibiotic long-term use - Z79.2; Ventricula...",70 to 75,"acetaminophen 325 mg oral tablet; albuterol 90 mcg/actuation inhalation HFA aerosol inhaler; aspirin EC 81 mg oral tablet,delayed release (DR/EC); atorvastatin 80 mg oral tablet; fluticasone propion-salmeteroL 250-50 mcg/dose inhalation blister with device; furosemide 40 mg oral tablet; gabapentin 300 mg oral capsule; isosorbide mononitrate CR 60 mg oral tablet extended release 24 hr; metoprolol succinate 25 mg oral tablet extended release 24 hr; nitroglycerin 0.4 mg sublingual tablet, sublingual; oxyCODONE (immediate release) 5 mg oral tablet; polyethylene glycol 17 gram/dose oral powder; potassium chloride 10 mEq oral tablet,ER particles/crystals; tiotropium 18 mcg inhalation capsule, w/inhalation device",5,11/1/2021,1
1053,,,7426140,1988-03-26,M,2021-09-14,Detected,"1.88 m (6' 2"")",(!) 113.4 kg (250 lb),36.7 °C (98.1 °F),82,143,85,Former Smoker,8.0,,"Second degree burn of back of hand [T23.269A]
Second degree burn of knee [T24.229A]",Second degree burn of back of hand - T23.269A; Second degree burn of knee - T24.229A,,"EPINEPHrine 0.3 mg/0.3 mL injection auto-injector; famotidine 20 mg oral tablet; fluticasone propionate 50 mcg/actuation nasal spray,suspension; predniSONE 5 mg oral tablet",1,11/12/2021,1
1057,,,6160340,1969-03-27,M,2021-09-14,Detected,"1.702 m (5' 7"")",97.5 kg (215 lb),36.7 °C (98.1 °F),83,157,68,Former Smoker,,"2019 novel coronavirus disease (COVID-19)
Diabetes mellitus type 2 in obese (HCC)
Hypertension
Hyperlipidemia
Bell's palsy
Psoas syndrome","Mixed hyperlipidemia [E78.2]
Diabetes mellitus type 2 in obese (HCC) [E11.69, E66.9]
Asthma
Acute hypoxemic respiratory failure due to COVID-19 (HCC) [U07.1, J96.01]
Pneumonia due to COVID-19 virus [U07.1, J12.82]
Acute respiratory failure with hypoxia (HCC) [J96.01]","Mixed hyperlipidemia - E78.2; Diabetes mellitus type 2 in obese (HCC) - E11.69, E66.9; Pneumonia due to COVID-19 virus - U07.1, J12.82",,"acetaminophen 325 mg oral tablet; aspirin EC 81 mg oral tablet,delayed release (DR/EC); dulaglutide (TRULICITY) 0.75 mg/0.5 mL subcutaneous pen injector; insulin glargine U-300 conc (TOUJEO SOLOSTAR U-300 INSULIN) 300 unit/mL (1.5 mL) subcutaneous insulin pen; LORazepam 0.5 mg oral tablet; losartan 25 mg oral tablet; rosuvastatin 40 mg oral tablet",2,10/15/2021,1
1081,,,7791583,2009-04-21,F,2021-09-14,Detected,"164 cm (5' 4.57"")",56 kg (123 lb 7.3 oz),37.3 °C (99.1 °F),(!) 107,98,60,Never Smoker,,"Acne
History of sexual violence
Transgender",,,,,1,11/8/2021,1
1083,,,6397943,1982-10-11,F,2021-09-14,Detected,"1.6 m (5' 3"")",83.9 kg (185 lb),36.7 °C (98.1 °F),88,126,84,Current Some Day Smoker,,"Migraines
Chronic pelvic pain in female
Ekbom's delusional parasitosis (HCC)
Advanced maternal age during pregnancy","Low back pain with sciatica [M54.40]
Mixed anxiety depressive disorder [F41.8]
Abdominal pain [R10.9]
Anxiety [F41.9]
Arthralgia of hip [M25.559]
Back pain [M54.9]
Encounter for counseling [Z71.9]
Allergic bronchitis [J45.909]
Cervical dysplasia [N87.9]
Constipation [K59.00]
Elevated blood pressure [IMO0001]
Palpitations [R00.2]
Migraine with aura [G43.109]
Opioid dependence with opioid-induced mood disorder (HCC) [F11.24]
...","Low back pain with sciatica - M54.40; Mixed anxiety depressive disorder - F41.8; Abdominal pain - R10.9; Arthralgia of hip - M25.559; Back pain - M54.9; Allergic bronchitis - J45.909; Cervical dysplasia - N87.9; Constipation - K59.00; Elevated blood pressure - IMO0001; Palpitations - R00.2; Migraine with aura - G43.109; Tenosynovitis of hand - M65.9; Opioid dependence on agonist therapy (HCC) - F11.20; Pelvic pain in female - R10.2; Sacroiliac joint pain - M53.3; Pudendal neuralgia - G58.8; High risk social situation - Z60.9; Ekbom's delusional parasitosis (HCC) - F22; Opioid use disorder, moderate, in sustained remission, on maintenance therapy (HCC) - F11.21; Post traumatic stress disorder (PTSD) - F43.10; Tobacco use disorder - F17.200; Attention deficit hyperactivity disorder (ADHD) - F90.9; Gastroesophageal reflux disease without esophagitis - K21.9; Vision disturbance - H53.9; Temporomandibular joint disorder - M26.609; Sleep disorder - G47.9; Postnasal drip - R09.82; Narcotic drug use - F11.90; Iron deficiency anemia - D50.9; History of postpartum hemorrhage - Z87.59; Essential hypertension - I10; Difficulty sleeping - G47.9; Chronic pain - G89.29; Buprenorphine maintenance treatment complicating pregnancy (HCC) - O99.320, F11.20; Family relationship problem - Z63.9; Diarrhea - R19.7",,"albuterol 90 mcg/actuation inhalation HFA aerosol inhaler; buprenorphine HCL 8 mg sublingual tablet, sublingual; buprenorphine HCL 8 mg sublingual tablet, sublingual; buprenorphine HCL 8 mg sublingual tablet, sublingual; cloNIDine HCL 0.1 mg oral tablet; GABAPENTIN 600 mg oral tablet; lisinopriL 20 mg oral tablet; ondansetron ODT 4 mg oral tablet,disintegrating; PANTOPRAZOLE 40 mg oral tablet,delayed release (DR/EC); SUMATRIPTAN 100 mg oral tablet",1,3/20/2021,1
1132,,,6906470,1991-01-26,M,2021-09-13,Detected,1.829 m (6'),54.7 kg (120 lb 8 oz),36.8 °C (98.2 °F),94,112,72,"Smoker, Current Status Unknown",5.0,"Vitiligo
Methamphetamine abuse (HCC)
Systolic dysfunction
GERD (gastroesophageal reflux disease)
Hyperlipidemia
Severe protein-calorie malnutrition (HCC)
Constipation
Type 1 diabetes mellitus (HCC)","Closed fracture of left tibial plateau with routine healing [S82.142D]
DKA, type 1 (HCC) [E10.10]
Type 1 diabetes mellitus with ketoacidosis and without coma (HCC) [E10.10]
Dehydration [E86.0]
Hyperkalemia [E87.5]
Type I diabetes mellitus (HCC) [E10.9]
HLD (hyperlipidemia) [E78.5]
Tobacco dependence [F17.200]
Diabetic ketoacidosis without coma associated with type 1 diabetes mellitus (HCC) [E10.10]
Hypovolemia [E86.1]
...","Type I diabetes mellitus (HCC) - E10.9; HLD (hyperlipidemia) - E78.5; Tobacco dependence - F17.200; Acute renal failure (ARF) (HCC) - N17.9; Vitiligo - L80; Severe protein-calorie malnutrition (HCC) - E43; Non compliance with medical treatment - Z91.19; Hematuria - R31.9; Proteinuria - R80.9; Systolic dysfunction - I51.9; Tachycardia - R00.0; Facial abscess - L02.01; History of methamphetamine use - Z87.898; Slow transit constipation - K59.01; Hyperglycemia - R73.9; Impetigo - L01.00; Diabetic ketosis (HCC) - E13.10; Diabetic ketoacidosis with coma associated with type 1 diabetes mellitus (HCC) - E10.11; DKA, type 1, not at goal (HCC) - E10.10; Acute COVID-19 - U07.1; Diabetic ketoacidosis without coma associated with type 1 diabetes mellitus (HCC) - E10.10; Sepsis, due to unspecified organism, unspecified whether acute organ dysfunction present (HCC) - A41.9; 2019 novel coronavirus disease (COVID-19) - U07.1",,"acetaminophen 325 mg oral tablet; Blood Sugar Diagnostic (FREESTYLE LITE STRIPS) miscellaneous (misc) strip; ferrous sulfate 325 mg total salt (65 mg elemental) oral tablet; glucagon (GLUCAGON) 1 mg injection recon soln; insulin aspart U-100 100 unit/mL (3 mL) subcutaneous insulin pen; insulin degludec 100 unit/mL (3 mL) subcutaneous insulin pen; Insulin Syringe-Needle U-100 (INSULIN SYRINGE) 1 mL 29 gauge x 1/2"" miscellaneous (misc) syringe; ketoconazole 2 % topical cream; mupirocin 2 % topical ointment",2,1/15/2021,1
1158,,,8159959,1982-07-19,F,2021-09-12,Detected,"1.68 m (5' 6.14"")",108.5 kg (239 lb 4.8 oz),36.9 °C (98.4 °F),95,153,(!) 94,Never Smoker,,"DM hyperosmolarity type II, uncontrolled (HCC)
Pneumonia due to 2019 novel coronavirus
Acute respiratory distress syndrome (ARDS) due to COVID-19 virus (HCC)
History of extracorporeal life support (ECLS)
MSSA (methicillin susceptible Staphylococcus aureus) pneumonia (HCC)","Acute respiratory distress syndrome (ARDS) due to COVID-19 virus (HCC) [U07.1, J80]
DM hyperosmolarity type II, uncontrolled (HCC) [E11.00, E11.65]
Adult BMI 40.0-44.9 kg/sq m (HCC) [Z68.41]
Pneumonia due to 2019 novel coronavirus [U07.1, J12.82]
History of extracorporeal life support (ECLS) [Z92.81]
OHSU RESEARCH PROTOCOL PATIENT (RESPRO)
MSSA (methicillin susceptible Staphylococcus aureus) pneumonia (HCC) [J15.211]
...","DM hyperosmolarity type II, uncontrolled (HCC) - E11.00, E11.65; Adult BMI 40.0-44.9 kg/sq m (HCC) - Z68.41; Acute deep vein thrombosis (DVT) of non-extremity vein - I82.90; Wound of skin - T14.8XXA; Blood loss anemia - D50.0; Weakness - R53.1; LVH (left ventricular hypertrophy) - I51.7; Hypertension - I10",55 to 60,"apixaban (ELIQUIS) 5 mg oral tablet; Blood Sugar Diagnostic (ONETOUCH VERIO TEST STRIPS) miscellaneous (misc) strip; cholecalciferol (vitamin D3) 10 mcg/5 mL (400 unit/5 mL) oral liquid; cyanocobalamin 500 mcg oral tablet; empagliflozin 10 mg oral tablet; empty container (SHARPS CONTAINER) miscellaneous (misc) misc; gabapentin 300 mg oral capsule; glucagon (GLUCAGON EMERGENCY KIT (HUMAN)) 1 mg injection recon soln; insulin glargine (LANTUS SOLOSTAR U-100 INSULIN) 100 unit/mL (3 mL) subcutaneous insulin pen; insulin glargine 100 unit/mL (3 mL) subcutaneous insulin pen; Insulin Needles (Disposable) (BD INSULIN PEN NEEDLE UF) 29 gauge x 1/2"" miscellaneous (misc) needle; lancets 33 gauge miscellaneous (misc) misc; levonorgestreL (MIRENA) 20 mcg/24 hours (7 yrs) 52 mg intrauterine intrauterine device; lisinopriL-hydrochlorothiazide 10-12.5 mg oral tablet; melatonin 3 mg oral capsule; zinc acetate 25 mg (zinc) oral capsule",2,,1
